keyword
https://read.qxmd.com/read/38747543/three-dimensional-telomere-profiling-predicts-risk-of-progression-in-smoldering-multiple-myeloma
#1
JOURNAL ARTICLE
Shaji Kumar, S Vincent Rajkumar, Dragan Jevremovic, Robert A Kyle, Yulia Shifrin, Michelle Nguyen, Zahabiya Husain, Asieh Alikhah, Anita Jafari, Sabine Mai, Kenneth Anderson, Sherif Louis
Smoldering multiple myeloma (SMM) is a precursor stage that precedes multiple myeloma (MM). SMM is heterogenous with nearly 40% of patients progressing to MM in the first 5 years. The high rate of progression of SMM patients highlights the need for early intervention, which underscores the importance of identifying SMM patients with the highest risk of progression. Several risk stratification models showed utility in identifying high-risk SMM patients; however, these systems showed limited sensitivity...
May 15, 2024: American Journal of Hematology
https://read.qxmd.com/read/38747304/characterization-of-discordance-between-mismatch-repair-deficiency-and-microsatellite-instability-testing-may-prevent-inappropriate-treatment-with-immunotherapy
#2
JOURNAL ARTICLE
Birgit S Geurts, Laurien J Zeverijn, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, Louisa R Hoes, Gijs F de Wit, Ilse Ac Spiekman, Thomas W Battaglia, Daphne M van Beek, Paul Roepman, Anne Ml Jansen, Wendy Wj de Leng, Annegien Broeks, Mariette Labots, Carla Ml van Herpen, Hans Gelderblom, Henk Mw Verheul, Petur Snaebjornsson, Emile E Voest
In the Drug Rediscovery Protocol (DRUP), patients with cancer are treated based on their tumor molecular profile with approved targeted and immunotherapies outside the labeled indication. Importantly, patients undergo a tumor biopsy for whole-genome sequencing (WGS) which allows for a WGS-based evaluation of routine diagnostics. Notably, we observed that not all biopsies of patients with dMMR/MSI-positive tumors as determined by routine diagnostics were classified as microsatellite-unstable by subsequent WGS...
May 15, 2024: Journal of Pathology
https://read.qxmd.com/read/38746379/sustained-inactivation-of-the-polycomb-prc1-complex-induces-dna-repair-defects-and-genomic-instability-in-epigenetic-tumors
#3
Chetan C Rawal, Vincent Loubiere, Nadejda L Butova, Juliette Garcia, Victoria Parreno, Anne-Marie Martinez, Giacomo Cavalli, Irene Chiolo
Cancer initiation and progression are typically associated with the accumulation of driver mutations and genomic instability. However, recent studies demonstrated that cancers can also be purely initiated by epigenetic alterations, without driver mutations. Specifically, a 24-hours transient down-regulation of polyhomeotic (ph-KD), a core component of the Polycomb complex PRC1, is sufficient to drive epigenetically initiated cancers (EICs) in Drosophila, which are proficient in DNA repair and are characterized by a stable genome...
April 24, 2024: Research Square
https://read.qxmd.com/read/38736683/rnmpid-a-database-for-ribonucleoside-monophosphates-in-dna
#4
JOURNAL ARTICLE
Jingcheng Yang, Mo Sun, Zihan Ran, Taehwan Yang, Deepali L Kundnani, Francesca Storici, Penghao Xu
MOTIVATION: Ribonucleoside monophosphates (rNMPs) are the most abundant non-standard nucleotides embedded in genomic DNA. If the presence of rNMP in DNA cannot be controlled, it can lead to genome instability. The actual regulatory functions of rNMPs in DNA remain mainly unknown. Considering the association between rNMP embedment and various diseases and cancer, the phenomenon of rNMP embedment in DNA has become a prominent area of research in recent years. RESULTS: We introduce the rNMPID database, which is the first database revealing rNMP-embedment characteristics, strand bias, and preferred incorporation patterns in the genomic DNA of samples from bacterial to human cells of different genetic backgrounds...
2024: Bioinform Adv
https://read.qxmd.com/read/38736486/molecular-and-immune-characterization-of-chinese-early-stage-non-squamous-non-small-cell-lung-cancer-a-multi-omics-cohort-study
#5
JOURNAL ARTICLE
Haoxin Peng, Xiangrong Wu, Xiaoli Cui, Shaopeng Liu, Yueting Liang, Xiuyu Cai, Mengping Shi, Ran Zhong, Caichen Li, Jun Liu, Dongfang Wu, Zhibo Gao, Xu Lu, Haitao Luo, Jianxing He, Wenhua Liang
BACKGROUND: Albeit considered with superior survival, around 30% of the early-stage non-squamous non-small cell lung cancer (Ns-NSCLC) patients relapse within 5 years, suggesting unique biology. However, the biological characteristics of early-stage Ns-NSCLC, especially in the Chinese population, are still unclear. METHODS: Multi-omics interrogation of early-stage Ns-NSCLC (stage I-III), paired blood samples and normal lung tissues (n=76) by whole-exome sequencing (WES), RNA sequencing, and T-cell receptor (TCR) sequencing were conducted...
April 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38734703/the-deubiquitinating-enzyme-usp4-regulates-brca1-stability-and-function
#6
JOURNAL ARTICLE
Xueyuan Guo, Yanfang Ma, Ting Zhang, Runyu Liu, Fen Chang, Xingyue Yan, Tianyun Yu, Pengfei Wu, Qin Li, Luzheng Xu, Junyi Duan, Li Li, Yanrong Su, Genze Shao
BRCA1 plays a suppressive role in breast tumorigenesis. Ubiquitin-dependent degradation is a common mechanism that regulates BRCA1 protein stability, and several ubiquitin ligases involved have been identified. However, the deubiquitinating enzyme for BRCA1 remains less defined. Here, we report that the deubiquitinase USP4 interacts with, deubiquitinates and stabilizes BRCA1, maintaining the protein level of BRCA1. USP4 knockdown results in a decreased BRCA1 protein level, impairment in homologous recombination mediated double-stranded break repair, and increased genome instability, and confers resistance to DNA damage-inducing agents and PARP inhibitors...
May 11, 2024: NPJ Breast Cancer
https://read.qxmd.com/read/38733827/the-macrophage-migration-inhibitory-factor-is-a-vital-player-in-pan-cancer-by-functioning-as-a-m0-macrophage-biomarker
#7
JOURNAL ARTICLE
Yuting Pu, Guifang Yang, Yang Zhou, Xiaogao Pan, Tuo Guo, Xiangping Chai
BACKGROUND: The role of the macrophage migration inhibitory factor (MIF) has recently attracted considerable attention in cancer research; nonetheless, the insights provided by current investigations remain constrained. Our main objective was to investigate its role and the latent mechanisms within the pan-cancer realm. METHODS: We used comprehensive pan-cancer bulk sequencing data and online network tools to investigate the association between MIF expression and patient prognosis, genomic instability, cancer cell stemness, DNA damage repair, and immune infiltration...
May 10, 2024: International Immunopharmacology
https://read.qxmd.com/read/38732200/a-nanorobotics-based-approach-of-breast-cancer-in-the-nanotechnology-era
#8
REVIEW
Anca-Narcisa Neagu, Taniya Jayaweera, Krishan Weraduwage, Costel C Darie
We are living in an era of advanced nanoscience and nanotechnology. Numerous nanomaterials, culminating in nanorobots, have demonstrated ingenious applications in biomedicine, including breast cancer (BC) nano-theranostics. To solve the complicated problem of BC heterogeneity, non-targeted drug distribution, invasive diagnostics or surgery, resistance to classic onco-therapies and real-time monitoring of tumors, nanorobots are designed to perform multiple tasks at a small scale, even at the organelles or molecular level...
May 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38732140/unveiling-the-dynamics-behind-glioblastoma-multiforme-single-cell-data-heterogeneity
#9
JOURNAL ARTICLE
Marcos Guilherme Vieira Junior, Adriano Maurício de Almeida Côrtes, Flávia Raquel Gonçalves Carneiro, Nicolas Carels, Fabrício Alves Barbosa da Silva
Glioblastoma Multiforme is a brain tumor distinguished by its aggressiveness. We suggested that this aggressiveness leads single-cell RNA-sequence data (scRNA-seq) to span a representative portion of the cancer attractors domain. This conjecture allowed us to interpret the scRNA-seq heterogeneity as reflecting a representative trajectory within the attractor's domain. We considered factors such as genomic instability to characterize the cancer dynamics through stochastic fixed points. The fixed points were derived from centroids obtained through various clustering methods to verify our method sensitivity...
April 30, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38730612/the-causes-and-consequences-of-dna-damage-and-chromosomal-instability-induced-by-human-papillomavirus
#10
REVIEW
Kathryn M Jones, Ava Bryan, Emily McCunn, Pate E Lantz, Hunter Blalock, Isabel C Ojeda, Kavi Mehta, Pippa F Cosper
High-risk human papillomaviruses (HPVs) are the main cause of cervical, oropharyngeal, and anogenital cancers, which are all treated with definitive chemoradiation therapy when locally advanced. HPV proteins are known to exploit the host DNA damage response to enable viral replication and the epithelial differentiation protocol. This has far-reaching consequences for the host genome, as the DNA damage response is critical for the maintenance of genomic stability. HPV+ cells therefore have increased DNA damage, leading to widespread genomic instability, a hallmark of cancer, which can contribute to tumorigenesis...
April 25, 2024: Cancers
https://read.qxmd.com/read/38717906/protocol-for-mapping-physiological-dsbs-using-in-suspension-break-labeling-in-situ-and-sequencing
#11
JOURNAL ARTICLE
Osama Hidmi, Sara Oster, Diala Shatleh, Jonathan Monin, Rami I Aqeilan
Physiological double-stranded breaks (DSBs) are a major source of genomic instability. Here, we present a protocol for mapping physiological DSBs by in-suspension break labeling in situ and sequencing (sBLISS) in a single-nucleotide resolution. We describe steps for cell fixation, labeling of DSBs, DNA isolation followed by in vitro transcription (IVT), reverse transcription, and library preparation. sBLISS provides a map of DSBs over the genome and can be used to study the role of different factors in DSB formation...
May 7, 2024: STAR protocols
https://read.qxmd.com/read/38717153/molecular-landscape-and-clinical-implication-of-ccne1-amplified-esophagogastric-cancer
#12
JOURNAL ARTICLE
Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Cyclin E overexpression as a result of CCNE1 amplification is a critical driver of genomic instability in gastric cancer, but its clinical implication is largely unknown. Thus, we integrated genomic, transcriptomic, and immune profiling analysis of 7,083 esophagogastric tumors and investigated the impact of CCNE1 amplification on molecular features and treatment outcomes. We identified CCNE1 amplification in 6.2% of esophageal adenocarcinoma samples, 7.0% of esophagogastric junction carcinoma, 4.2% of gastric adenocarcinoma samples, and 0...
May 8, 2024: Cancer Res Commun
https://read.qxmd.com/read/38715404/gastric-cancer-molecular-classification-based-on-immunohistochemistry-and-in-situ-hybridisation-and-mortality
#13
JOURNAL ARTICLE
Maarit Eskuri, Eva-Maria Birkman, Joonas H Kauppila
BACKGROUND AND AIMS: Gastric cancers (GC) are divided into subtypes based on molecular profile: Epstein-Barr virus (EBV)-positive, microsatellite instability (MSI), chromosomal instability (CIN) and genomically stable (GS) tumours. The prognostic impact of this classification is unclear. The aim was to evaluate whether the molecular subtypes determined using in-situ hybridisation (ISH) and immunohistochemistry (IHC) are associated with clinicopathological parameters and prognosis. METHODS AND RESULTS: The study included 503 GC patients...
May 7, 2024: Histopathology
https://read.qxmd.com/read/38712633/liquid-biomarkers-in-prostate-cancer-recent-advancements-and-future-directions
#14
JOURNAL ARTICLE
Chris Ho-Ming Wong, Ivan Ching-Ho Ko, Chi Fai Ng
PURPOSE OF REVIEW: Traditional diagnostic approaches of prostate cancer like PSA are limited by high false-positive rates and insufficient capture of tumour heterogeneity, necessitating the development of more precise tools. This review examines the latest advancements in liquid biomarkers for prostate cancer, focusing on their potential to refine diagnostic accuracy and monitor disease progression. RECENT FINDINGS: Liquid biomarkers have gained prominence because of their minimally invasive nature and ability to reflect the molecular characteristics of prostate cancer...
May 7, 2024: Current Opinion in Urology
https://read.qxmd.com/read/38712090/human-polymerase-theta-helicase-positions-dna-microhomologies-for-double-strand-break-repair
#15
Christopher J Zerio, Yonghong Bai, Brian A Sosa-Alvarado, Timothy Guzi, Gabriel C Lander
DNA double-strand breaks occur in all human cells on a daily basis and must be repaired with high fidelity to minimize genomic instability 1 . Deficiencies in high-fidelity DNA repair by homologous recombination lead to dependence on DNA polymerase theta, which identifies DNA microhomologies in 3' single-stranded DNA overhangs and anneals them to initiate error-prone double-strand break repair. The resulting genomic instability is associated with numerous cancers, thereby making this polymerase an attractive therapeutic target 2,3 ...
April 27, 2024: bioRxiv
https://read.qxmd.com/read/38710020/phenotypic-genomic-and-transcriptomic-heterogeneity-in-a-pancreatic-cancer-cell-line
#16
JOURNAL ARTICLE
Gengqiang Xie, Liting Zhang, Olalekan H Usman, Sampath Kumar, Chaity Modak, Dhenu Patel, Megan Kavanaugh, Xian Mallory, Yue Julia Wang, Jerome Irianto
OBJECTIVES: To evaluate the suitability of the MIA PaCa-2 cell line for studying pancreatic cancer intratumor heterogeneity, we aim to further characterize the nature of MIA PaCa-2 cells' phenotypic, genomic, and transcriptomic heterogeneity. METHODS: MIA PaCa-2 single-cell clones were established through flow cytometry. For the phenotypic study, we quantified the cellular morphology, proliferation rate, migration potential, and drug sensitivity of the clones. The chromosome copy number and transcriptomic profiles were quantified using SNPa and RNA-seq, respectively...
May 6, 2024: Pancreas
https://read.qxmd.com/read/38709532/kras-allelic-variants-in-biliary-tract-cancers
#17
MULTICENTER STUDY
Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric-Bernstam, Elisabeth Kathleen Kong, Dean Pavlick, Jeffrey S Ross, Karthikeyan Murugesan, Lawrence Kwong, Anaemy Danner De Armas, Anil Korkut, Milind Javle, Jennifer J Knox
IMPORTANCE: Biliary tract cancers (BTCs) contain several actionable molecular alterations, including FGFR2, IDH1, ERBB2 (formerly HER2), and KRAS. KRAS allelic variants are found in 20% to 30% of BTCs, and multiple KRAS inhibitors are currently under clinical investigation. OBJECTIVES: To describe the genomic landscape, co-sequence variations, immunophenotype, genomic ancestry, and survival outcomes of KRAS-mutated BTCs and to calculate the median overall survival (mOS) for the most common allelic variants...
May 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38708718/wdr61-ablation-triggers-r-loop-accumulation-and-suppresses-breast-cancer-progression
#18
JOURNAL ARTICLE
Yayan Hou, Chunyong Zhang, Ling Liu, Ying Yu, Lei Shi, Yan Qin
Although, superkiller complex protein 8 (SKI8), previously known as WDR61 has been identified and mapped in breast tumor, little is currently known about its function. This study aims to elucidate the role of WDR61 in breast tumor development and its potential as a therapeutic target. Here, we show that tamoxifen-induced knockout of Wdr61 reduces the risk of breast tumors, resulting in smaller tumor size and weight, and improved overall survival. Furthermore, we show that knockdown of WDR61 compromises the proliferation of breast tumor cells with reduced colony-forming capacity...
May 6, 2024: FEBS Journal
https://read.qxmd.com/read/38707337/stimulator-of-interferon-genes-mediated-immune-senescence-reveals-the-immune-microenvironment-and-prognostic-characteristics-of-bladder-cancer
#19
JOURNAL ARTICLE
Zhijun Yao, Lin Yang, Xiaorong Yang, Fang Liu, Bin Fu, Jing Xiong
BACKGROUND: Studies have shown that the stimulator of interferon genes (STING) is critical in tumorigenesis, and development. This study aimed to investigate the immune profile and prognostic significance of STING-mediated immune senescence in bladder cancer (BLCA). METHODS: We identified differential genes between tumor and normal tissue based on the Cancer Genome Atlas database, and used consensus clustering to identify BLCA subtypes. The genes most associated with overall survival were screened by further analysis and used to construct risk models...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38706903/identification-of-the-expression-of-tie1-and-its-mediated-immunosuppression-in-gastric-cancer
#20
JOURNAL ARTICLE
Zhenqi Gong, Qing Zheng, Baizhi Li, Huaiming Wang, Hongwu Chen, Shaoxiong Lin
Background: Recently, various evidence has confirmed that Tyrosine Kinase with Immunoglobulin-like and EGF-like domains 1 (TIE1) promotes tumor growth in many cancers. However, the precise mechanism underlying TIE1's involvement in Gastric Cancer (GC) remains elusive. This research aimed to investigate the biological function of TIE1 in regulating GC progression. Methods: The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), GEPIA2.0, Sangerbox3.0 and TIMER databases were used to analyze the TIE1 expression...
2024: Journal of Cancer
keyword
keyword
104874
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.